You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dupilumab

Showing 26 - 50 of 97
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Real Life Experience Survey of Dupilumab in the Netherlands

Enrolling by invitation
  • Severe Asthma
  • Dupilumab
  • Rotterdam, Netherlands
    Franciscus Gasthuis & Vlietland
Apr 16, 2022

Eosinophilic Esophagitis Trial in Philadelphia (Eosinophilic Esophagitis (EoE) food introduction-1st, Eosinophilic Esophagitis

Recruiting
  • Eosinophilic Esophagitis
  • Eosinophilic Esophagitis (EoE) food introduction-1st
  • +3 more
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jul 25, 2022

Asthma Trial in United States (Dupilumab, Placebo)

Recruiting
  • Asthma
  • Dupilumab
  • Placebo
  • Boston, Massachusetts
  • +6 more
Dec 5, 2022

AERD - Aspirin Exacerbated Respiratory Disease Trial in Vienna (Dupilumab)

Recruiting
  • AERD - Aspirin Exacerbated Respiratory Disease
  • Dupilumab
  • Vienna, Austria
    Medical University of Vienna
Apr 5, 2022

Alopecia Areata Trial in New York (Dupilumab, Placebo)

Completed
Has Results
  • Alopecia Areata
  • Dupilumab
  • Placebo
  • New York, New York
  • +1 more
Aug 16, 2022

Nasal Polyps, Asthma, Aspirin-Induced, Aspirin-Exacerbated Respiratory Disease Trial in Boston (Dupilumab, Placebo)

Not yet recruiting
  • Nasal Polyps
  • +3 more
  • Dupilumab
  • Placebo
  • Boston, Massachusetts
    Brigham and Women's Hospital
Oct 7, 2022

Asthma Trial in United States (Dupilumab, Placebo)

Recruiting
  • Asthma
  • Dupilumab
  • Placebo
  • Aurora, Colorado
  • +6 more
Jun 1, 2022

Peanut Allergy Trial in Canada, United States (Dupilumab)

Completed
Has Results
  • Peanut Allergy
  • Dupilumab
  • Mountain View, California
  • +8 more
May 17, 2022

Being Conducted in Women With Atopic Dermatitis (AD)

Recruiting
  • Adverse Pregnancy Outcomes
  • Atopic Dermatitis
  • dupilumab
  • Boston, Massachusetts
    Regeneron Research Site
Feb 3, 2022

Eczema, Atopic Dermatitis Trial in New York (Dupilumab, Optical Coherence Tomography, Reflectance confocal microscopy)

Recruiting
  • Eczema
  • Atopic Dermatitis
  • Dupilumab
  • +2 more
  • New York, New York
    OptiSkin Medical
Feb 22, 2022

Allergic Contact Dermatitis Trial in Boston (Dupilumab)

Recruiting
  • Allergic Contact Dermatitis
  • Dupilumab
  • Boston, Massachusetts
    Brigham and Women's Hospital, Department of Dermatology
Oct 12, 2021

Covid19 Trial in Charlottesville (Dupilumab, Placebo)

Active, not recruiting
  • Covid19
  • Dupilumab
  • Placebo
  • Charlottesville, Virginia
    UVA Health
Mar 31, 2022

Prostate Cancer Trial in Baltimore (Dupilumab)

Terminated
Has Results
  • Prostate Cancer
  • Dupilumab
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Sep 17, 2021

Chronic Spontaneous Urticaria, Recurrent Angioedema Trial in Germany (Dupilumab, Placebo)

Completed
  • Chronic Spontaneous Urticaria
  • Recurrent Angioedema
  • Dupilumab
  • Placebo
  • Marburg, Hessen, Germany
  • +5 more
Feb 1, 2022

Aspirin-exacerbated Respiratory Disease Trial (Dupilumab, Placebo)

Not yet recruiting
  • Aspirin-exacerbated Respiratory Disease
  • Dupilumab
  • Placebo
  • (no location specified)
Aug 31, 2021

Metastatic NSCLC Trial in New York (Dupilumab, PD-1/PD-L1 blockade)

Recruiting
  • Metastatic Non-small Cell Lung Cancer
  • Dupilumab
  • PD-1/PD-L1 blockade
  • New York, New York
    Tisch Cancer Institute, Mount Sinai Hospital
Sep 29, 2021

Chronic Hand Eczema Trial in Bordeaux, Montpellier, Toulouse (Dupilumab, )

Recruiting
  • Chronic Hand Eczema
  • Dupilumab
  • placebo
  • Bordeaux, France
  • +2 more
Sep 3, 2021

Atopic Dermatitis (AD) Trial in United States (Dupilumab, Placebo)

Terminated
Has Results
  • Atopic Dermatitis (AD)
  • Dupilumab
  • Placebo
  • La Jolla, California
  • +8 more
Sep 7, 2021

Atopic Dermatitis Trial in Scottsdale (Dupilumab, Photo therapy)

Recruiting
  • Atopic Dermatitis
  • Dupilumab
  • Photo therapy
  • Scottsdale, Arizona
    Mayo Clinic Arizona
Sep 29, 2022

Atopic Dermatitis Trial in China (Dupilumab, Placebo, Emollient (moisturizer))

Completed
Has Results
  • Atopic Dermatitis
  • Dupilumab
  • +2 more
  • Beijing, China
  • +26 more
Mar 15, 2022

North America to Monitor Pregnancy and Infant Outcomes Following

Recruiting
  • Atopic Dermatitis (AD)
  • Asthma
  • dupilumab
  • La Jolla, California
    Regeneron Research Site
Jul 28, 2021

Bullous Pemphigoid Trial in Worldwide (dupilumab, Matching Placebo, Oral corticosteroids (OCS))

Recruiting
  • Bullous Pemphigoid
  • dupilumab
  • +2 more
  • Scottsdale, Arizona
  • +50 more
Jan 13, 2023

Atopic Keratoconjunctivitis Trial in United States (Dupilumab)

Recruiting
  • Atopic Keratoconjunctivitis
  • Dupilumab
  • Los Angeles, California
  • +12 more
Nov 23, 2021

Molecular Signatures in Inflammatory Skin Disease

Recruiting
  • Atopic Dermatitis
  • Psoriasis
  • Kiel, Germany
    Department of Dermatology, University Hospital Schleswig Holstei
Jul 16, 2022

Asthma Trial in Ann Arbor (Dupilumab)

Recruiting
  • Asthma
  • Dupilumab
  • Ann Arbor, Michigan
    University of Michigan
Mar 3, 2022